Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity
International Journal of Biological Sciences · 2024
DOI: 10.7150/ijbs.88500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Chan Shan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China.
- Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266021, China.
Zitieren
APA
Shan, C., Liang, Y., Wang, K., & Li, P. (2024). Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.88500
Vancouver
Shan C, Liang Y, Wang K, Li P. Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity. International Journal of Biological Sciences. 2024. doi:10.7150/ijbs.88500
BibTeX
@article{Shan2024,
author = {Shan, Chan and Liang, Yan and Wang, Kun and Li, Peifeng},
title = {Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity},
journal = {International Journal of Biological Sciences},
year = {2024},
doi = {10.7150/ijbs.88500}
}
EUVIMED